Federico Grossi - 15 Mar 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
15 Mar 2022
Net transactions value
+$15,331
Form type
4
Filing time
17 Mar 2022, 18:19:49 UTC
Previous filing
02 Mar 2022
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $30,170 +7,000 +6.4% $4.31* 116,811 15 Mar 2022 Direct
transaction APLS Common Stock Sale $14,839 -375 -0.32% $39.57 116,436 15 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -7,000 -12% $0.000000 50,723 15 Mar 2022 Common Stock 7,000 $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.
F2 This stock option was granted on 08/21/2017 and is fully vested.